Jennifer M Jones, Jaimin Bhatt, Jonathan Avery, Andreas Laupacis, Katherine Cowan, Naveen S Basappa, Joan Basiuk, Christina Canil, Sohaib Al-Asaaed, Daniel Y C Heng, Lori Wood, Dawn Stacey, Christian Kollmannsberger, Michael A S Jewett
Author Information
Jennifer M Jones: Cancer Rehabilitation and Survivorship Program, Princess Margaret Cancer Centre, University Health Network, and Department of Psychiatry, University of Toronto, Toronto, Canada. Electronic address: jennifer.jones@uhn.ca.
Jaimin Bhatt: Departments of Surgery and Surgical Oncology (Division of Urology), Princess Margaret Cancer Centre, University Health Network, and the University of Toronto, Toronto, Canada.
Jonathan Avery: School of Rehabilitation Sciences, University of Ottawa, Ottawa, Canada.
Andreas Laupacis: Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Canada.
Katherine Cowan: James Lind Alliance, Southampton, UK.
Naveen S Basappa: Cross Cancer Institute, Department of Oncology, University of Alberta, Edmonton, Canada.
Joan Basiuk: Kidney Cancer Research Network of Canada.
Christina Canil: Department of Internal Medicine, Division of Medical Oncology, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Canada.
Sohaib Al-Asaaed: Division of Medical Oncology, Memorial University of Newfoundland, St. John's, Canada.
Daniel Y C Heng: Department of Medical Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Canada.
Lori Wood: Division of Medical Oncology, Department of Urology, Dalhousie University, Halifax, Canada.
Dawn Stacey: Faculty of Health Sciences, School of Nursing and Ottawa Hospital Research Institute, Ottawa, Canada.
Christian Kollmannsberger: Medical Oncology, University of British Columbia and Medical Oncology BC Cancer Agency.
Michael A S Jewett: Departments of Surgery and Surgical Oncology (Division of Urology), Princess Margaret Cancer Centre, University Health Network, and the University of Toronto, Toronto, Canada.
Defining disease-specific research priorities in cancer can facilitate better allocation of limited resources. Involving patients and caregivers as well as expert clinicians in this process is of value. We undertook this approach for kidney cancer as an example. The Kidney Cancer Research Network of Canada sponsored a collaborative consensus-based priority-setting partnership that identified ten research priorities in the management of kidney cancer. These are discussed in the context of current initiatives and gaps in knowledge.
